| Literature DB >> 24553609 |
Uju M E Dibua1, Ifeoma S Onyemerela1, Emeka I Nweze1.
Abstract
OBJECTIVE: This study was designed to determine the frequency and causative agent(s) of urinary tract infections (UTIs) in individuals with symptoms of urinary tract infections in Enugu State of Southeast Nigeria, and to determine the antibiotic susceptibility pattern of microbial agents isolated from urine culture.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24553609 PMCID: PMC4085832 DOI: 10.1590/S0036-46652014000100008
Source DB: PubMed Journal: Rev Inst Med Trop Sao Paulo ISSN: 0036-4665 Impact factor: 1.846
Antibiotic susceptibility test result against Gram - positive UTI isolates
| Urine isolates (No.) | ANTIBIOTIC TESTED | % resistance | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | SXT | E | PEF | CN | APX | Z | AM | R | CPX | ||
|
| + | + | + | + | + | + | + | + | + | - | 90 |
|
| + | - | - | - | - | + | + | + | - | - | 40 |
|
| - | + | + | - | +/- | + | + | + | - | - | 60 |
|
| - | - | + | - | - | + | + | + | - | - | 40 |
|
| - | - | + | + | - | + | + | + | + | + | 70 |
|
| - | - | + | - | - | + | + | + | - | - | 40 |
|
| - | - | - | - | - | + | + | + | + | - | 40 |
|
| +/- | + | + | - | - | + | + | + | - | - | 60 |
|
| + | + | + | + | + | + | + | + | + | - | 90 |
|
| - | - | - | - | - | + | + | + | - | - | 30 |
|
| + | - | + | - | - | + | + | + | - | - | 50 |
|
| - | - | - | - | - | +/- | + | + | - | - | 30 |
|
| - | + | + | - | +/- | + | + | + | - | - | 60 |
|
| - | - | + | - | - | + | + | + | - | - | 40 |
| Total resistance (%) | 35.71 | 35.71 | 71.43 | 21.43 | 28.57 | 100 | 100 | 100 | 28.57 | 7.14 | |
- = susceptible; +/- = intermediate; + = resistant; sp = species; S = Septrin 30 µg, E = Erythromycin 10 µg, PEF = Pefloxacin 10 µg, CN = Gentamycin 10 µg, APX = Ampiclox 30 µg, Z = Zinnacef 20 µg, AM = Amoxacillin 30 µg, R = Rocephin 30 µg and CPX = Ciprofloxacin 10 µg.
Antibiotic susceptibility test result against Gram – negative UTI isolates
| Urine isolates (No.) | ANTIBIOTIC TESTED | % resistance | |||||||||
| SXT | CH | SP | CPX | AM | AU | CN | PEF | OFX | S | ||
|
| + | + | + | + | + | + | +/- | + | + | +/- | 100 |
|
| +/- | - | +/- | - | +/- | - | - | - | - | +/- | 40 |
|
| - | - | + | - | - | - | - | - | - | - | 10 |
|
| + | + | + | +/- | + | + | +/- | + | +/- | + | 100 |
|
| + | + | + | + | + | + | - | + | + | + | 90 |
|
| + | + | + | + | + | + | + | + | + | +/- | 100 |
|
| + | + | + | + | + | + | + | + | + | +/- | 100 |
|
| + | + | + | + | + | + | +/- | + | + | +/- | 100 |
|
| - | - | + | + | + | - | - | - | - | - | 30 |
|
| + | + | + | - | - | - | - | +/- | +/- | +/- | 60 |
|
| + | - | + | + | + | + | + | + | + | +/- | 90 |
|
| + | + | + | + | + | + | + | + | + | +/- | 100 |
|
| + | - | - | - | +/- | + | + | - | - | + | 50 |
|
| + | + | + | +/- | + | + | +/- | - | - | +/- | 80 |
|
| + | + | + | - | + | + | - | - | - | + | 60 |
|
| - | - | - | - | - | + | - | - | - | - | 10 |
|
| + | + | + | - | + | +/- | - | + | + | - | 70 |
|
| + | + | + | - | + | + | - | - | - | - | 50 |
|
| +/- | + | - | - | - | + | - | - | - | - | 30 |
|
| +/- | + | - | - | - | + | - | - | - | - | 30 |
|
| + | + | + | - | - | + | - | - | - | - | 40 |
|
| + | + | + | - | - | + | - | - | - | - | 40 |
|
| + | + | + | + | + | + | - | + | + | - | 80 |
| % resistance | 87.0 | 73.9 | 82.6 | 47.8 | 69.6 | 82.6 | 39.1 | 47.8 | 47.8 | 56.5 | |
- = susceptible; +/- = intermediate; + = resistant; spp = species, SXT = 30 µg septrin; CH = 30 µg chloramphenicol; SP = 10 µg sparfloxacin; CPX = 10 µg ciprofloxacin; AM = 30 µg Amoxacillin; AU = 30 µg Augmentin; CN = 10 µg Gentamycin; PEF = 30 µg perfloxacin; OFX = 10 µg tarivid; S = 30 µg streptomycin.